Medicofarma Biotech Spolka Akcyjna Logo

Medicofarma Biotech Spolka Akcyjna

MDB | WAR

Overview

Corporate Details

ISIN(s):
PLINBOK00010
LEI:
259400W39H7UHW9EJP66
Country:
Poland
Address:
Warszawa Sokołowska 9/U19, 01-142 Warszawa
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Medicofarma Biotech is a research and development company operating in the biotechnology sector. The company's primary mission is to design, refine, and commercialize innovative medications, medical devices, and biotechnological products. It focuses on developing breakthrough therapies for the prevention and treatment of modern-age diseases, with a noted concentration on innovative oncological therapies. Through its dedicated R&D Center, Medicofarma Biotech collaborates with pharmaceutical manufacturers, cosmetic companies, and scientific institutions, providing expert support and access to modern equipment for the initial preformulation stages of generic and cosmetic product development.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Medicofarma Biotech Spolka Akcyjna. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-04-18 18:43
Share Issue/Capital Change
Wprowadzenie do ASO na rynku NewConnect akcji serii G i H oraz złożenie wniosku…
Polish 1.3 KB
2024-03-06 19:35
Capital/Financing Update
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
Polish 3.3 KB
2024-01-03 22:51
Share Issue/Capital Change
Złożenie wniosku o wprowadzenie akcji serii G i H do obrotu w ASO na rynku NewC…
Polish 1.7 KB
2024-01-02 17:16
Share Issue/Capital Change
Korekta raportu bieżącego ESPI nr 11/2023 - Content (PL)
Polish 4.5 KB
2023-12-31 19:41
Capital/Financing Update
Zawarcie kolejnego aneksu do umowy pożyczki z podmiotami powiązanymi - Content …
Polish 2.1 KB
2023-12-31 19:33
Legal Proceedings Report
Zawarcie umów ograniczających rozporządzanie akcjami Spółki - Content (PL)
Polish 2.9 KB
2023-12-31 19:24
Investor Presentation
Strategia na lata 2024-2026
Polish 2.6 MB
2023-12-31 19:24
Business and Financial Review
Przyjęcie strategii Spółki na lata 2024 - 2026 - Content (PL)
Polish 1.8 KB
2023-10-26 22:42
Capital/Financing Update
Zawarcie aneksu do umowy pożyczki z podmiotami powiązanymi - Content (PL)
Polish 2.5 KB
2023-10-23 20:42
Regulatory News Service
Zawarcie umowy o dofinansowanie projektu wybranego w ramach konkursu NUTRITECH …
Polish 6.3 KB
2023-10-11 21:07
Legal Proceedings Report
Otrzymanie wyników wstępnego międzynarodowego poszukiwania dot. stanu techniki …
Polish 1.9 KB
2023-07-20 19:38
Report Publication Announcement
Najwyższa ocena merytoryczna wniosku dotacyjnego NUTRITECH - Content (PL)
Polish 1.2 KB
2023-07-19 18:01
Regulatory News Service
Informacja o uzyskaniu certyfikatu GMP - Content (PL)
Polish 716 bytes
2023-06-30 22:59
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Walnym Zgroma…
Polish 766 bytes
2023-06-02 15:22
Management Discussion and Analysis
Medicofarma_Biotech_SA_Sprawozdanie_Rady_Nadzorczej_2022_20230602_sent.pdf
Polish 345.3 KB

Automate Your Workflow. Get a real-time feed of all Medicofarma Biotech Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Medicofarma Biotech Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
THERACRYF PLC Logo
Developing sulforaphane-based therapeutics for oncology and behavioural brain disorders.
United Kingdom TCF
Theranexus Logo
Biopharma developing drug candidates for rare neurological diseases like Batten disease.
France ALTHX
TME Pharma N.V. Logo
Clinical-stage biotech developing TME-targeting therapies for aggressive cancers.
Germany ALTME
Toleranzia AB Logo
Developing immune therapies for rare autoimmune diseases like myasthenia gravis.
Sweden TOL
Transgene Logo
Clinical-stage biotech using viral vectors for cancer vaccines and oncolytic viruses.
France TNG
Tvardi Therapeutics Inc. Logo United States of America TVRD
UCAR Logo
A nonprofit consortium managing atmospheric research and providing resources to the scientific community.
France ALUCR
Hong Kong N/A
Urteste S.A. Logo
Developing non-invasive urine tests for early detection & monitoring of multiple cancers.
Poland URT
VALIRX PLC Logo
Developing early-stage therapeutics & diagnostics for oncology and women's health.
United Kingdom VAL